ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow Report
|
|
jazzapat
|
3 |
2.6K |
3 |
30/04/19 |
30/04/19 |
ASX - By Stock
|
3
|
2.6K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
FDA meeting
|
|
jazzapat
|
14 |
5.6K |
4 |
22/03/19 |
22/03/19 |
ASX - By Stock
|
14
|
5.6K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Appendix 3B
|
|
jazzapat
|
4 |
7.7K |
1 |
20/03/19 |
20/03/19 |
ASX - By Stock
|
4
|
7.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Shareholder Update March 2019
|
|
jazzapat
|
47 |
76K |
1 |
20/03/19 |
20/03/19 |
ASX - By Stock
|
47
|
76K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Shareholder Update March 2019
|
|
jazzapat
|
47 |
76K |
1 |
19/03/19 |
19/03/19 |
ASX - By Stock
|
47
|
76K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
DEP always first
|
|
jazzapat
|
21 |
7.2K |
5 |
15/03/19 |
15/03/19 |
ASX - By Stock
|
21
|
7.2K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
DEP always first
|
|
jazzapat
|
21 |
7.2K |
4 |
15/03/19 |
15/03/19 |
ASX - By Stock
|
21
|
7.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Cheap as chips.....I'm topping up....are you
|
|
jazzapat
|
3 |
1.4K |
1 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Leaky ship........I smell an announcement
|
|
jazzapat
|
22 |
9.7K |
3 |
05/03/19 |
05/03/19 |
ASX - By Stock
|
22
|
9.7K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Adios amigos
|
|
jazzapat
|
24 |
13K |
2 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
24
|
13K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow Report
|
|
jazzapat
|
17 |
8.1K |
6 |
31/01/19 |
31/01/19 |
ASX - By Stock
|
17
|
8.1K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Sorry I Could Not Stay Out
|
|
jazzapat
|
4 |
1.9K |
11 |
22/01/19 |
22/01/19 |
ASX - By Stock
|
4
|
1.9K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Shareholder Update January 2019
|
|
jazzapat
|
90 |
38K |
9 |
18/01/19 |
18/01/19 |
ASX - By Stock
|
90
|
38K
|
9
|
|
ASX - By Stock
|
RDF |
Re:
Ann: Q2 FY19 Sales Activity Update
|
|
jazzapat
|
10 |
3.2K |
1 |
12/01/19 |
12/01/19 |
ASX - By Stock
|
10
|
3.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Let's move on
|
|
jazzapat
|
124 |
49K |
3 |
11/01/19 |
11/01/19 |
ASX - By Stock
|
124
|
49K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Let's move on
|
|
jazzapat
|
124 |
49K |
2 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
124
|
49K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
jazzapat
|
158 |
77K |
3 |
02/01/19 |
02/01/19 |
ASX - By Stock
|
158
|
77K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US patent granted for SPL7013 eye drops for conjunctivitis
|
|
jazzapat
|
32 |
13K |
4 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
32
|
13K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
No news prior to Xmas
|
|
jazzapat
|
13 |
8.1K |
7 |
08/12/18 |
08/12/18 |
ASX - By Stock
|
13
|
8.1K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
No news prior to Xmas
|
|
jazzapat
|
13 |
8.1K |
14 |
08/12/18 |
08/12/18 |
ASX - By Stock
|
13
|
8.1K
|
14
|
|
ASX - By Stock
|
IFL |
Re:
Ann: IOOF response to APRA notice and action
|
|
jazzapat
|
160 |
67K |
4 |
07/12/18 |
07/12/18 |
ASX - By Stock
|
160
|
67K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Broker predictions/Pound of flesh
|
|
jazzapat
|
38 |
10K |
3 |
27/11/18 |
27/11/18 |
ASX - By Stock
|
38
|
10K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP products outperform in human pancreatic cancer model
|
|
jazzapat
|
38 |
14K |
3 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
38
|
14K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP products outperform in human pancreatic cancer model
|
|
jazzapat
|
38 |
14K |
7 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
38
|
14K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Ask the CEO directly at AGM
|
|
jazzapat
|
11 |
3.7K |
1 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
11
|
3.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ask the CEO directly at AGM
|
|
jazzapat
|
11 |
3.7K |
10 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
11
|
3.7K
|
10
|
|
ASX - By Stock
|
SPL |
Re:
Are AstraZeneca preparing to purchase spl
|
|
jazzapat
|
73 |
28K |
12 |
10/11/18 |
10/11/18 |
ASX - By Stock
|
73
|
28K
|
12
|
|
ASX - By Stock
|
SPL |
Re:
Whats your interpretation on the US Vivagel Partnership people
|
|
jazzapat
|
7 |
4.5K |
16 |
31/10/18 |
31/10/18 |
ASX - By Stock
|
7
|
4.5K
|
16
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Ceasing to be a substantial holder
|
|
jazzapat
|
15 |
6.5K |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
15
|
6.5K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in substantial holding
|
|
jazzapat
|
10 |
5.9K |
0 |
14/09/18 |
14/09/18 |
ASX - By Stock
|
10
|
5.9K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Something to think about
|
|
jazzapat
|
31 |
12K |
3 |
13/09/18 |
13/09/18 |
ASX - By Stock
|
31
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP irinotecan outperforms in pancreatic cancer model
|
|
jazzapat
|
69 |
28K |
5 |
05/09/18 |
05/09/18 |
ASX - By Stock
|
69
|
28K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AstraZeneca DEP Bcl2/xL inhibitors show compelling efficacy
|
|
jazzapat
|
51 |
21K |
3 |
01/09/18 |
01/09/18 |
ASX - By Stock
|
51
|
21K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AstraZeneca DEP Bcl2/xL inhibitors show compelling efficacy
|
|
jazzapat
|
51 |
21K |
7 |
01/09/18 |
01/09/18 |
ASX - By Stock
|
51
|
21K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
US Vivagel deal
|
|
jazzapat
|
4 |
1.6K |
3 |
29/08/18 |
29/08/18 |
ASX - By Stock
|
4
|
1.6K
|
3
|
|
ASX - By Stock
|
TME |
Re:
Ann: Preliminary Final Report
|
|
jazzapat
|
43 |
17K |
0 |
22/08/18 |
22/08/18 |
ASX - By Stock
|
43
|
17K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Great Annual Report - Just need to drill in and read it carefully
|
|
jazzapat
|
10 |
6.4K |
2 |
22/08/18 |
22/08/18 |
ASX - By Stock
|
10
|
6.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Annual report and full year financial results
|
|
jazzapat
|
32 |
12K |
3 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
32
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Annual report and full year financial results
|
|
jazzapat
|
32 |
12K |
11 |
21/08/18 |
21/08/18 |
ASX - By Stock
|
32
|
12K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
Are AstraZeneca preparing to purchase spl
|
|
jazzapat
|
73 |
28K |
1 |
16/08/18 |
16/08/18 |
ASX - By Stock
|
73
|
28K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Are AstraZeneca preparing to purchase spl
|
|
jazzapat
|
73 |
28K |
7 |
16/08/18 |
16/08/18 |
ASX - By Stock
|
73
|
28K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Tardiness in spl
|
|
jazzapat
|
20 |
9.1K |
1 |
14/08/18 |
14/08/18 |
ASX - By Stock
|
20
|
9.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Tardiness in spl
|
|
jazzapat
|
20 |
9.1K |
1 |
13/08/18 |
13/08/18 |
ASX - By Stock
|
20
|
9.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Not much money needed to shift SPL down 3%
|
|
jazzapat
|
17 |
6.8K |
1 |
10/08/18 |
10/08/18 |
ASX - By Stock
|
17
|
6.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Very high volume
|
|
jazzapat
|
26 |
11K |
3 |
01/08/18 |
01/08/18 |
ASX - By Stock
|
26
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
SP strength
|
|
jazzapat
|
34 |
15K |
1 |
27/07/18 |
27/07/18 |
ASX - By Stock
|
34
|
15K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
SP strength
|
|
jazzapat
|
34 |
15K |
5 |
25/07/18 |
25/07/18 |
ASX - By Stock
|
34
|
15K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Technical update
|
|
jazzapat
|
21 |
10K |
1 |
24/07/18 |
24/07/18 |
ASX - By Stock
|
21
|
10K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow Report
|
|
jazzapat
|
24 |
9.7K |
2 |
17/07/18 |
17/07/18 |
ASX - By Stock
|
24
|
9.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Cashflow Report
|
|
jazzapat
|
24 |
9.7K |
1 |
17/07/18 |
17/07/18 |
ASX - By Stock
|
24
|
9.7K
|
1
|
|